11th Apr 2016 08:57
LONDON (Alliance News) - EKF Diagnostics Holdings PLC, the medical diagnostics business listed on London's AIM market, on Monday said its former chairman resigned as a non-executive director with immediate effect.
The resignation of Ron Zwanziger as a non-executive director comes after the point-of-care business on Friday named Christopher Mills, the chief executive and owner of Harwood Capital Management Ltd, as its non-executive chairman.
Ron Zwanziger, the former chief executive officer of New York-listed Alere Inc, had been appointed as chairman in November.
The North Atlantic Smaller Companies Investment Trust PLC and Oryx International Growth Fund Ltd together own a 19.24% stake in EKF. Mills is the manager of both the fund and the trust.
North Atlantic Smaller Companies Investment Trust took its 10.95% stake in EKF in March, according to a document filed by EKF on March 21. The same document showed that Oryx International Growth Fund increased its stake to 8.29%, by adding 1.8 million shares to the 33.2 million it already had in EKF.
Shares in EKF were up 0.50% at 12.69 pence on Monday morning.
By Samuel Agini; [email protected]; @samuelagini
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Ekf Diagnostics